Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |